Horizon Discovery

Sector:
Pharmaceuticals & Biotechnology
Exit:
Placement of blocks of shares on AIM

horizon discovery

Most Recent Exit In Price/Share Average Out Price/Share
  2016  £0.87  £1.59

Horizon Discovery is a world leader in the application of gene editing technologies, which are used for research into, and treatment of, genetically-based diseases.

Calculus Capital exited its holding in 2016, via a placement of shares on the AIM. The average exit multiple for sale of the shares was 1.82x, constituting a tax free return of over 160%, when factoring in initial investor income tax relief of 30%. The investment was held for 3 years, 3 months.